Idera Pharmaceuticals Inc.

(IDRA) Trade

By |

Profile

Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates. The 3GA technology is used to create drug candidates to turn off the RNA messengers associated with genes causing various diseases.

Contact Information

Website: www.iderapharma.com
Email: rdoody@iderapharma.com
Main Phone: +1 484 348-1600
Address: 505 Eagleview Boulevard
Address 2: Suite 212
State: PA
City / Town: Exton
Country: USA
Postal Code: 19341

Issuer Information

Exchange: NSC
CEO: Vincent J. Milano
Employees: 36
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

Idera Pharmaceuticals Inc is a clinical-stage biopharmaceutical company involved in the discovery, development, and commercialization of innovative therapeutics for oncology and rare diseases. The company has developed two distinct proprietary drug-discovery technology platforms: Toll-like receptor and third-generation antisense technology. The Toll-like receptor technology helped the company create synthetic oligonucleotide-based drug candidates. The 3GA technology is used to create drug candidates to turn off the RNA messengers associated with genes causing various diseases.

Contact Information

Website: www.iderapharma.com
Email: rdoody@iderapharma.com
Main Phone: +1 484 348-1600
Address: 505 Eagleview Boulevard
Address 2: Suite 212
State: PA
City / Town: Exton
Country: USA
Postal Code: 19341

Issuer Information

Exchange: NSC
CEO: Vincent J. Milano
Employees: 36
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 2.75 $ 0. (0.00%)
Last Price 2.75 Change $ 0. Change % 0.00 Tick N/A
Bid 2.50 Bid Size 9,000.00 Ask 3.00 Ask Size 300.00
Open N/A High N/A Low N/A Prev Close 2.75
Last Trade Volume 0 52 Wk Hi 12.00 52 Wk Low 2.25
Market Cap 77.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 28,021,756.00 EPS (TTM) -1.86 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 13
Number of Buys 0 13
Number of Sells 0 0
Net Activity 0 113802
Last 10 Buys Shares
Julian C. Baker 1,000
Julian C. Baker 1,000
Youssef El-Zein 1,000
Maxine Gowen 1,000
James A. Geraghty 1,000
Mark J. Casey 1,000
Vincent J. Milano 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Vincent J. Milano 1,000
Last 10 Sell Shares
Youssef El-Zein 1,000
Youssef El-Zein 1,000
Youssef El-Zein 1,000
Youssef El-Zein 1,000
Youssef El-Zein 1,000
Youssef El-Zein 1,000
Youssef El-Zein 1,000
Youssef El-Zein 1,000
Youssef El-Zein 1,000
Youssef El-Zein 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5 5 5 5
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 4.67 4.67 4.67 4.33
Standard Deviation 0.58 0.58 0.58 0.58
Date of Most Recent Estimate 06/04/18 05/09/18 05/09/18 06/12/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 3 3 3 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1